ICON Public Limited Company logo
ICON Public Limited Company ICLR
$ 176.57 -3.31%

Annual report 2024
added 01-10-2026

report update icon

ICON Public Limited Company Balance Sheet 2011-2026 | ICLR

Annual Balance Sheet ICON Public Limited Company

2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Net Debt

4.63 B -467 M - -46.6 M 66 M 156 M 244 M -119 M -182 M -114 M -119 M

Long Term Debt

3.4 B 3.67 B 4.6 B 5.38 B 348 M - 349 M 349 M 349 M 348 M - - - -

Long Term Debt Current

- - - - 24.3 M 28.3 M - - - - - - - -

Total Non Current Liabilities

- - - - 461 M 158 M 389 M 390 M 386 M 382 M 40.3 M 30.7 M 34.1 M 47 M

Total Current Liabilities

2.8 B 2.83 B 2.69 B 2.48 B 1.12 B 1.13 B 611 M 566 M 494 M 572 M 538 M 501 M 413 M 307 M

Total Liabilities

7.35 B 7.75 B 8.69 B 9.32 B 1.59 B 1.25 B 1 B 956 M 881 M 954 M 579 M 532 M 448 M 354 M

Deferred Revenue

1.61 B 1.65 B 1.51 B 1.32 B 661 M 367 M 274 M - - - - - - -

Retained Earnings

2.72 B 2.43 B 1.82 B 1.42 B 1.26 B 1.11 B 888 M 744 M 589 M 437 M 655 M 624 M 521 M 481 M

Total Assets

16.9 B 17 B 17.2 B 17.4 B 3.44 B 2.91 B 2.35 B 2.15 B 1.83 B 1.72 B 1.53 B 1.44 B 1.2 B 1.04 B

Cash and Cash Equivalents

- - - 752 M 840 M 520 M 396 M 283 M 193 M 104 M 119 M 183 M 114 M 119 M

Book Value

9.52 B 9.24 B 8.5 B 8.07 B 1.85 B 1.66 B 1.35 B 1.19 B 945 M 763 M 950 M 911 M 755 M 682 M

Total Shareholders Equity

9.52 B 9.24 B 8.5 B 8.07 B 1.85 B 1.62 B 1.35 B 1.19 B 945 M 763 M 950 M 911 M 755 M 682 M

All numbers in USD currency

Quarterly Balance Sheet ICON Public Limited Company

2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Long Term Debt

- - - 5.09 B 5.38 B 5.95 B 47.3 M 52.2 M 348 M 62.5 M 64 M 74.8 M 76.6 M 79.4 M 79.6 M 83.2 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Total Liabilities

- - - 9.09 B 9.32 B 9.69 B 1.56 B 1.53 B 1.59 B 1.35 B 1.28 B 1.33 B 1.25 B 1.21 B 1.19 B 1.19 B 1 B 991 M 936 M 1.01 B 956 M 926 M 875 M 911 M 881 M - - - 954 M - - - - - - - - - - - - - - - - - - -

Deferred Revenue

- - - 1.3 B 1.32 B 1.35 B 675 M 610 M 661 M 451 M 393 M 386 M 367 M 322 M 321 M 318 M 274 M 354 M 327 M 332 M 299 M 262 M 261 M 267 M 273 M 251 M 258 M 318 M 319 M 295 M 268 M 253 M 280 M 294 M 291 M 270 M 297 M 283 M 272 M 222 M 219 M 186 M 195 M 169 M 151 M 137 M 142 M 143 M

Retained Earnings

- - - 1.43 B 1.42 B 1.34 B 1.43 B 1.36 B 1.26 B 1.16 B 1.07 B 1.02 B 1.11 B 1.02 B 1 B 952 M 888 M 872 M 790 M 735 M 743 M 697 M 623 M 569 M 588 M 624 M 560 M 499 M 436 M 543 M 711 M 711 M 655 M 707 M 689 M 660 M 624 M 590 M 562 M 540 M 521 M 500 M 482 M 489 M 481 M 486 M 489 M 476 M

Total Assets

- - - 17.2 B 17.4 B 17.7 B 3.58 B 3.47 B 3.44 B 3.07 B 2.86 B 2.84 B 2.91 B 2.75 B 2.72 B 2.61 B 2.35 B 2.33 B 2.17 B 2.22 B 2.15 B 2.05 B 1.9 B 1.86 B 1.83 B 1.9 B 1.75 B 1.8 B 1.72 B 1.81 B 1.64 B 1.6 B 1.53 B 1.57 B 1.53 B 1.48 B 1.44 B 1.36 B 1.29 B 1.23 B 1.2 B 1.14 B 1.1 B 1.13 B 1.03 B 1.05 B 1.01 B 1.01 B

Cash and Cash Equivalents

- - - 559 M 752 M 1.01 B 1.06 B 942 M 840 M 708 M 592 M 482 M 520 M 418 M 370 M 418 M 396 M 426 M 289 M 272 M 283 M 210 M 228 M 237 M 193 M 219 M 168 M 161 M 104 M 235 M 107 M 95.2 M 119 M 154 M 81.3 M 237 M 183 M 156 M 98.3 M 137 M 114 M 119 M 94.9 M 129 M 119 M 127 M 176 M 192 M

Book Value

- - - 8.07 B 8.07 B 7.97 B 2.03 B 1.93 B 1.85 B 1.71 B 1.58 B 1.51 B 1.66 B 1.54 B 1.53 B 1.42 B 1.35 B 1.33 B 1.24 B 1.2 B 1.19 B 1.13 B 1.03 B 945 M 945 M 1.9 B 1.75 B 1.8 B 763 M 1.81 B 1.64 B 1.6 B 1.53 B 1.57 B 1.53 B 1.48 B 1.44 B 1.36 B 1.29 B 1.23 B 1.2 B 1.14 B 1.1 B 1.13 B 1.03 B 1.05 B 1.01 B 1.01 B

Total Shareholders Equity

- - - 8.07 B 8.07 B 7.97 B 2.03 B 1.93 B 1.85 B 1.71 B 1.58 B 1.51 B 1.62 B 1.5 B 1.5 B 1.42 B 1.35 B 1.33 B 1.24 B 1.2 B 1.19 B 1.13 B 1.03 B 945 M 945 M 992 M 910 M 844 M 763 M 863 M 1.02 B 999 M 950 M 1.01 B 998 M 961 M 911 M 855 M 802 M 768 M 755 M 719 M 684 M 702 M 682 M 697 M 712 M 693 M

All numbers in USD currency

Balance Sheet is a fundamental financial report of ICON Public Limited Company, providing a complete picture of the company’s financial position at a specific point in time. Unlike the income statement, which records the results of operations over a certain period, the balance sheet shows what assets the company owns, what liabilities it has to creditors, and what equity is available to the owners.

For an investor, the balance sheet is important because it allows assessing the company’s financial stability, understanding how much debt it carries, and how dependent it is on borrowed financing. It helps calculate key liquidity and leverage ratios. When analyzing, attention should be paid to the debt-to-equity ratio (Debt/Equity), the amount of cash on the balance sheet, and the ratio of current liabilities to liquid assets.

Features of balance sheet analysis
  • Vertical and horizontal analysis
    Vertical analysis shows the structure of the balance sheet as a percentage of total assets or liabilities, while horizontal analysis shows the dynamics of changes over multiple periods.
  • Asset quality
    It is important to evaluate not only the amount of assets but also their liquidity and realizability.
  • Accounting for off-balance sheet liabilities
    Some liabilities may not be directly reflected in the balance sheet, which requires additional attention.

Balance sheet of other industry stocks – Diagnostics research

Issuer Price % 24h Market Cap Country
Akumin Akumin
AKU
- -17.87 % $ 25.9 M canadaCanada
Anixa Biosciences Anixa Biosciences
ANIX
$ 3.11 -2.51 % $ 101 K usaUSA
Centogene N.V. Centogene N.V.
CNTG
- -6.23 % $ 30.6 M germanyGermany
Accelerate Diagnostics Accelerate Diagnostics
AXDX
- -61.36 % $ 2.46 M usaUSA
Brainsway Ltd. Brainsway Ltd.
BWAY
$ 22.32 -3.71 % $ 99.4 M israelIsrael
BioNano Genomics BioNano Genomics
BNGO
$ 1.45 -3.67 % $ 1.84 M usaUSA
Aspira Women's Health Aspira Women's Health
AWH
- -6.19 % $ 10.5 M usaUSA
Burning Rock Biotech Limited Burning Rock Biotech Limited
BNR
$ 30.5 -4.72 % $ 328 M chinaChina
Biocept Biocept
BIOC
- -13.05 % $ 7.29 M usaUSA
Check-Cap Ltd. Check-Cap Ltd.
CHEK
- - $ 9.42 M israelIsrael
Castle Biosciences Castle Biosciences
CSTL
$ 40.78 1.92 % $ 1.13 B usaUSA
Co-Diagnostics Co-Diagnostics
CODX
- - $ 79.8 M usaUSA
DexCom DexCom
DXCM
$ 70.44 1.29 % $ 27.2 B usaUSA
Oxford Immunotec Global PLC Oxford Immunotec Global PLC
OXFD
- - $ 562 M britainBritain
Chembio Diagnostics Chembio Diagnostics
CEMI
- 0.22 % $ 16.8 M usaUSA
Guardant Health Guardant Health
GH
$ 113.62 1.32 % $ 13.9 B usaUSA
Global Cord Blood Corporation Global Cord Blood Corporation
CO
- - $ 399 M chinaChina
Fluidigm Corporation Fluidigm Corporation
FLDM
- 1.08 % $ 308 M usaUSA
Genetic Technologies Limited Genetic Technologies Limited
GENE
- - $ 7.1 B australiaAustralia
Genetron Holdings Limited Genetron Holdings Limited
GTH
- 0.12 % $ 80.1 M chinaChina
DermTech DermTech
DMTK
- -11.32 % $ 2.94 M usaUSA
PRA Health Sciences, Inc. PRA Health Sciences, Inc.
PRAH
- - $ 10.7 B usaUSA
Illumina Illumina
ILMN
$ 147.36 4.03 % $ 23.4 B usaUSA
CareDx, Inc CareDx, Inc
CDNA
$ 20.08 0.35 % $ 1.08 B usaUSA
Danaher Corporation Danaher Corporation
DHR
$ 234.95 -0.44 % $ 172 B usaUSA
Celcuity Celcuity
CELC
$ 105.63 -1.25 % $ 4.17 B usaUSA
DarioHealth Corp. DarioHealth Corp.
DRIO
$ 12.48 0.28 % $ 354 M israelIsrael
Enzo Biochem Enzo Biochem
ENZ
- -8.98 % $ 14.8 K usaUSA
Fulgent Genetics Fulgent Genetics
FLGT
$ 27.65 -1.53 % $ 836 M usaUSA
HTG Molecular Diagnostics HTG Molecular Diagnostics
HTGM
- -20.0 % $ 1.06 M usaUSA
Exact Sciences Corporation Exact Sciences Corporation
EXAS
$ 102.21 -0.22 % $ 18.9 B usaUSA
Lantheus Holdings Lantheus Holdings
LNTH
$ 66.02 2.75 % $ 4.57 B usaUSA
Medpace Holdings Medpace Holdings
MEDP
$ 602.32 -1.41 % $ 18.6 B usaUSA
IQVIA Holdings IQVIA Holdings
IQV
$ 234.18 -1.47 % $ 42.5 B usaUSA
QIAGEN N.V. QIAGEN N.V.
QGEN
- - $ 10.6 B niderlandNiderland
Heska Corporation Heska Corporation
HSKA
- - $ 1.31 B usaUSA
Neogen Corporation Neogen Corporation
NEOG
$ 9.28 0.27 % $ 2.01 B usaUSA
National Research Corporation National Research Corporation
NRC
$ 22.06 -0.72 % $ 541 M usaUSA
Charles River Laboratories International Charles River Laboratories International
CRL
$ 219.04 -0.3 % $ 11.3 B usaUSA
OPKO Health OPKO Health
OPK
$ 1.3 1.56 % $ 902 M usaUSA
Pacific Biosciences of California Pacific Biosciences of California
PACB
$ 2.36 6.79 % $ 599 M usaUSA
Quest Diagnostics Incorporated Quest Diagnostics Incorporated
DGX
$ 188.87 -0.33 % $ 21 B usaUSA
Biodesix Biodesix
BDSX
$ 8.85 12.25 % $ 1.15 B usaUSA
Mettler-Toledo International Mettler-Toledo International
MTD
$ 1 409.56 -3.5 % $ 29.9 B schweizSchweiz
Laboratory Corporation of America Holdings Laboratory Corporation of America Holdings
LH
$ 272.02 0.42 % $ 22.8 B usaUSA
IDEXX Laboratories IDEXX Laboratories
IDXX
$ 688.67 -3.73 % $ 56.8 B usaUSA
Myriad Genetics Myriad Genetics
MYGN
$ 5.65 -4.56 % $ 512 M usaUSA
ENDRA Life Sciences ENDRA Life Sciences
NDRA
$ 4.67 -2.3 % $ 2.51 M usaUSA
Agilent Technologies Agilent Technologies
A
$ 135.52 -2.95 % $ 41.2 B usaUSA